JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China flag China · Delayed Price · Currency is CNY
27.09
-0.11 (-0.40%)
At close: Jan 22, 2026

SHA:603235 Revenue

JiangXi Tianxin Pharmaceutical had revenue of 508.60M CNY in the quarter ending September 30, 2025, a decrease of -7.02%. This brings the company's revenue in the last twelve months to 2.23B, up 10.84% year-over-year. In the year 2024, JiangXi Tianxin Pharmaceutical had annual revenue of 2.21B with 17.35% growth.

Revenue (ttm)
2.23B
Revenue Growth
+10.84%
P/S Ratio
5.33
Revenue / Employee
830.88K
Employees
2,679
Market Cap
11.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.21B326.58M17.35%
Dec 31, 20231.88B-422.80M-18.34%
Dec 31, 20222.30B-217.64M-8.63%
Dec 31, 20212.52B218.84M9.50%
Dec 31, 20202.30B278.64M13.76%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition